ArticleScientific reports2026
Mixed reality navigation system for ultrasound-guided and fusion biopsies using markerless instrument tracking.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Percutaneous needle biopsy is commonly performed under ultrasound guidance to visualize the target lesion and monitor needle position. This study aims to improve spatial information for the operator by accurately visualizing the ultrasound image at its true anatomical location and scale within a head-mounted display, co-registered with pre-procedural imaging data. Current mixed reality systems rely on fiducial markers to track the instruments, which limits their practical utility in clinical settings; therefore, this study evaluated a custom markerless method for ultrasound probe tracking that achieved accuracy suitable for clinical applications. By displaying the ultrasound image relative to the probe's spatial position, the system enables seamless fusion with pre-procedural imaging data. Combined with markerless needle tracking, this approach provides a complete navigation solution. Target registration error analysis between 2D ultrasound and 3D computed tomography demonstrated a 95% likelihood that the error remains within 3.41 mm. A biopsy navigation assessment test confirmed the system's strong potential to reduce the number of puncture attempts compared to conventional ultrasound guidance alone. By providing comprehensive spatial and imaging information, the navigation system may contribute to reduced operator error and improved procedural success rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.